国: オーストラリア
言語: 英語
ソース: Department of Health (Therapeutic Goods Administration)
metaraminol tartrate, Quantity: 5.7 mg (Equivalent: metaraminol, Qty 3 mg)
Global Harvest Pharmaceuticals Pty Ltd
Injection, solution
Excipient Ingredients: sodium metabisulfite; sodium chloride; water for injections
Intravenous
5
(S4) Prescription Only Medicine
Prevention and treatment of the acute hypotensive state occurring with spinal anaesthesia; adjunctive treatment of hypotension due to haemorrhage, reactions to medications, surgical complications, and shock associated with brain damage due to tumour or trauma. It may also be useful as an adjunct in the treatment of hypotension due to cardiogenic shock or septicaemia
Visual Identification: Clear colourless sterile solution; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Registered
2019-06-07
CMI- METARAMINOL GH Pharma INJECTION Page 1 of 4 CONSUMER MEDICINE INFORMATION METARAMINOL GH PHARMA INJECTION METARAMINOL TARTRATE WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Metaraminol GH Pharma Injection. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risk of you being given Metaraminol GH Pharma Injection against the benefits it is expected to have for you. IF YOU HAVE ANY CONCERNS ABOUT BEING GIVEN THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may want to read it again. WHAT METARAMINOL GH PHARMA INJECTION IS USED FOR The name of your medicine is Metaraminol GH Pharma Injection. It contains the active ingredient Metaraminol tartrate. Metaraminol GH Pharma Injection is used to increase your blood pressure which can drop during spinal anaesthesia or can drop as a reaction to medications or surgical complications. Your doctor may have prescribed Metaraminol GH Pharma Injection for another reason. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY METARAMINOL GH PHARMA INJECTION WAS PRESCRIBED FOR YOU. Your doctor may have prescribed it for another reason. _ _ HOW METARAMINOL GH PHARMA INJECTION WORKS Metaraminol GH Pharma Injection belongs to a group of medicines known as sympathomimetic amines. It strengthens the contraction of the heart muscle and constricts blood vessels to help increase the blood pressure. There is no evidence that Metaraminol GH Pharma Injection is addictive. BEFORE YOU TAKE METARAMINOL GH PHARMA INJECTION WHEN YOU MUST NOT TAKE IT You should not be given Metaraminol GH Pharma Injection if: • You are allergic to the active ingredient or any of the inactive ingredients mentioned at the end of this leaflet under Product Description. Metaraminol GH CMI- METARAMINOL GH Pharma INJECTION Page 2 of 4 Pharma Injection contains sodium metabisulfite. A sulfite may cause an allergic- type re 完全なドキュメントを読む
Metaraminol GH Pharma V06-0519 Page 1 of 7 AUST R 99402 AUST R 300197, AUST R 304084 AUSTRALIAN PRODUCT INFORMATION METARAMINOL GH PHARMA INJECTION (METARAMINOL TARTRATE) 1 NAME OF THE MEDICINE Metaraminol tartrate 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Metaraminol tartrate is a white, crystalline powder, which is freely soluble in water, slightly soluble in alcohol, and practically insoluble in chloroform and in ether. ACTIVE INGREDIENT Metaraminol tartrate EXCIPIENTS For full list of excipients see Section 6.1 List of excipients 3 PHARMACEUTICAL FORM METARAMINOL GH PHARMA Injection is a clear colourless sterile solution. METARAMINOL GH PHARMA Injection is available as solution for injection containing metaraminol tartrate 10 mg/mL in clear glass ampoules and 3 mg/6 mL and 5 mg/10 mL in clear glass vials. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Prevention and treatment of the acute hypotensive state occurring with spinal anaesthesia; adjunctive treatment of hypotension due to haemorrhage, reactions to medications, surgical complications, and shock associated with brain damage due to tumour or trauma. It may also be useful as an adjunct in the treatment of hypotension due to cardiogenic shock or septicaemia. 4.2 DOSE AND METHOD OF ADMINISTRATION Metaraminol GH Pharma Injection is administered intravenously only (injection or infusion). The injection solution contains no antimicrobial preservative and is for single use in one patient only. Discard any residue. Because the maximum effect is not immediately apparent, at least ten minutes should elapse before increasing the dosage. As the effect tapers off when the vasopressor is discontinued, the patient should be carefully observed so that therapy can be reinitiated promptly if the blood pressure falls too rapidly. Patients with coexistent shock and acidosis may show a poor response to vasopressors. Established methods of shock management, such as blood or fluid replacement when indicated, and other measures directed to the specific cause of the shoc 完全なドキュメントを読む